ACTIVE

IMMUNO-CELL INTERNATIONAL

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result478,3 k €-8,3 %over 1 year

Gross margin975,4 k €-11,8 %over 1 year

Equity955,3 k €+45,4 %over 1 year

Workforce6,5 ETP-11,0 %over 1 year

Identity

Source · BCE/KBO

IMMUNO-CELL INTERNATIONAL is a Private limited company incorporated in 1994. Its registered office is in Mechelen. It employs on average 6,5 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0453.361.865
Incorporation: 01/08/1994
Legal form: Private limited company
Registered office: Motstraat 72 box 8
2800 Mechelen · FlandreSee on map
Contributed capital: 50 000,00 €
Latest accounts: 31/12/2025
Average workforce: 6,5 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	975,4 k €	-11.8%	1,1 M €	+5.8%	1 M €	-4.8%	1,1 M €	+10.3%	996,7 k €
EBITDA	730,8 k €	-5.3%	771,8 k €	+4.9%	736,1 k €	-13.2%	848,3 k €	+15.4%	735,3 k €
Operating result	654,9 k €	-4.2%	683,3 k €	+5.0%	650,5 k €	-15.6%	771 k €	+19.5%	645,3 k €
Net result	478,3 k €	-8.3%	521,8 k €	+2.2%	510,6 k €	-9.4%	563,6 k €	+18.2%	477 k €
Balance sheet
Equity	955,3 k €	+45.4%	657 k €	+35.4%	485,2 k €	+2.2%	474,6 k €	-44.9%	860,9 k €
Total assets	1,6 M €	+27.3%	1,2 M €	-26.9%	1,7 M €	-24.6%	2,2 M €	+24.1%	1,8 M €
Cash	191,4 k €	+3.3%	185,2 k €	-71.0%	639,3 k €	-1.5%	649,3 k €	-7.3%	700,7 k €
Debts	603,7 k €	+6.3%	567,9 k €	-52.1%	1,2 M €	-32.1%	1,7 M €	+88.2%	927,7 k €
Other
Workforce	6,5 ETP	-11.0%	7,3 ETP	+2.8%	7,1 ETP	+29.1%	5,5 ETP	-19.1%	6,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 7 ended

Active mandates

James Dehé

Director

Active

Quentin Speeckaert

Director

Active

Ended mandates

Alexander Laquiere

Director

Ended

Alexander Laquiere

Manager

Ended

Daniel Boterdael

Manager

Ended

Hanne Vermeeren

Director

Ended

Other companies at this address

Motstraat 72 2800 Mechelen

Company	CBE no.
COMMUNICATION AND MARKETING PRODUCTIONS● Active	0453.472.723
D.W. PRINT● Active	0451.676.144
EK REAL INVEST● Active	0419.183.520
Groep P1892● Active	1015.655.425
JACCO DESIGN● Active	0466.487.450
MaJor Green Solutions● Active	0782.767.135
PJB PEETERS GROEP● Active	0648.907.135
PJH INVEST● Active	0478.846.042
ProjeKt 1892● Active	0691.858.834
SCHILDER- & RENOVATIEWERKEN PJB PEETERS● Active	0641.822.670
Tradeway● Active	0890.203.840
UBIVISION● Active	0475.127.279
VDB ENGINEERING GROUP● Active	0727.892.552
WEES ORIGINEEL● Active	0879.341.127

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	08/06/2026	29/08/2025	30/07/2024	31/07/2023	16/08/2022	15/07/2021
General meeting	29/05/2026	30/06/2025	28/06/2024	30/06/2023	30/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	29/05/2026	08/06/2026	Dutch	PDF
Abridged model	31/12/2024	30/06/2025	29/08/2025	Dutch	PDF
Abridged model	31/12/2023	28/06/2024	30/07/2024	Dutch	PDF
Abridged model	31/12/2022	30/06/2023	31/07/2023	Dutch	PDF
Abridged model	31/12/2021	30/06/2022	16/08/2022	Dutch	PDF
Abridged model	31/12/2020	30/06/2021	15/07/2021	Dutch	PDF
Abridged model	31/12/2019	30/06/2020	29/08/2020	Dutch	PDF
Abridged model	31/12/2018	28/06/2019	19/07/2019	Dutch	PDF
Abridged model	31/12/2017	30/06/2018	28/07/2018	Dutch	PDF
Abridged model	31/12/2016	26/05/2017	05/07/2017	Dutch	PDF
Abridged model	31/12/2015	29/07/2016	10/08/2016	Dutch	PDF
Abridged model	31/12/2014	30/06/2015	29/09/2015	Dutch	PDF
Abridged model	31/12/2013	27/06/2014	29/08/2014	Dutch	PDF
Abridged model	31/12/2012	31/05/2013	27/09/2013	Dutch	PDF
Abridged model	31/12/2011	27/05/2012	09/08/2012	Dutch	PDF
Abridged model	31/12/2010	27/05/2011	22/06/2011	Dutch	PDF
Abridged model	31/12/2009	28/05/2010	25/06/2010	Dutch	PDF
Abridged model	31/12/2008	24/07/2009	07/08/2009	Dutch	PDF
Abridged model	31/12/2007	26/07/2008	28/08/2008	Dutch	PDF
Abridged model	31/12/2006	25/05/2007	21/06/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 7 ended

Active mandates

James Dehé

Director

Active

Quentin Speeckaert

Director

Active

Ended mandates

Alexander Laquiere

Director

Ended

Alexander Laquiere

Manager

Ended

Daniel Boterdael

Manager

Ended

Hanne Vermeeren

Director

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates22/01/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates26/10/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/10/2017
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares27/09/2016
KAPITAAL - AANDELEN
PDF
Capital / shares12/05/2009
KAPITAAL - AANDELEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025478,3 k €↓
2024
Annual accounts 2024521,8 k €↑
2023
Annual accounts 2023510,6 k €↓
2022
Annual accounts 2022563,6 k €↑
2021
Annual accounts 2021477 k €↓
2020
Annual accounts 2020533,5 k €↑
2019
Annual accounts 2019381,2 k €↑
2018
Annual accounts 2018306,3 k €↑
2017
Annual accounts 2017247 k €↓
2016
Annual accounts 2016282,9 k €↑
2015
Annual accounts 2015178,9 k €↑
2014
Annual accounts 2014127,5 k €↑
2013
Annual accounts 201361,1 k €↑
2012
Annual accounts 201236,3 k €↑
2011
Annual accounts 201130,1 k €↑
2010
Annual accounts 201023 k €↑
2009
Annual accounts 20092,5 k €↓
2008
Annual accounts 20089,5 k €↓
2007
Annual accounts 200724 k €↓
2006
Annual accounts 200644,7 k €
01/08/1994
IncorporationPrivate limited company

IMMUNO-CELL INTERNATIONAL

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline